Search Prime Grants

W81XWH2220004

Cooperative Agreement

Overview

Grant Description
Prevention of lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells.
Awardee
University Of Utah
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Salt Lake City, Utah 841129049 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH21BCRPTBCCA
University Of Utah was awarded Preventing Metastatic Breast Cancer by Eradicating DTCs Cooperative Agreement W81XWH2220004 worth $8,239,897 from Medical Command in August 2022 with work to be completed primarily in Salt Lake City Utah United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 8/6/22

Period of Performance
8/1/22
Start Date
7/31/26
End Date
77.0% Complete

Funding Split
$8.2M
Federal Obligation
$0.0
Non-Federal Obligation
$8.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2220004

Additional Detail

Award ID FAIN
W81XWH2220004
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
State Government
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
LL8GLEVH6MG3
Awardee CAGE
3T624
Performance District
02
Senators
Mike Lee
Mitt Romney
Representative
Chris Stewart

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $8,239,897 100%
Modified: 8/6/22